XML 29 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information (Tables)
9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Segment
    Three months ended September 30,   Nine months ended September 30,
Sale of Product   2017   2016   2017   2016
Radiochemical Products   $ 605,507   $ 433,394   $ 1,777,903   $ 1,216,587
Cobalt Products     116,750     67,653     420,816     573,308
Nuclear Medicine Standards     808,148     804,382     2,451,252     2,454,399
Radiological Services     349,565     99,807     844,898     460,874
Fluorine Products     -     -     -     -
Transportation     20,731     6,027     25,864     96,504
Total Segments     1,900,701     1,411,263     5,520,733     4,801,672
Corporate revenue     -     -     -     -
Total Consolidated   $ 1,900,701   $ 1,411,263   $ 5,520,733   $ 4,801,672
                         
    Three months ended September 30,   Nine months ended September 30,
Depreciation and Amortization   2017   2016   2017   2016
Radiochemical Products   $ 1,875   $ 1,748   $ 5,093   $ 5,246
Cobalt Products     8,468     10,056     27,322     33,747
Nuclear Medicine Standards     3,066     1,768     7,554     10,221
Radiological Services     9,494     8,755     28,928     24,471
Fluorine Products     28,491     28,030     85,337     83,990
Transportation     2,682     2,891     8,253     7,540
Total Segments     54,076     53,248     162,487     165,215
Corporate depreciation and amortization     1,197     1,828     3,649     5,027
Total Consolidated   $ 55,273   $ 55,076   $ 166,136   $ 170,242
                         
    Three months ended September 30,   Nine months ended September 30,
Segment Income (Loss)   2017   2016   2017   2016
Radiochemical Products   $ 113,906   $ 90,953   $ 339,059   $ 250,424
Cobalt Products     66,229     (4,516)     221,224     305,138
Nuclear Medicine Standards     124,876     178,265     504,510     540,065
Radiological Services     135,245     26,543     375,069     186,370
Fluorine Products     (37,135)     (102,055)     (178,170)     (297,355)
Transportation     415     (24,156)     (43,127)     (26,898)
Total Segments     403,536     165,034     1,218,565     957,744
Corporate loss     (1,985,701)     (704,391)     (4,189,193)     (2,317,046)
Net Loss   $ (1,582,165)   $ (539,357)   $ (2,970,628)   $ (1,359,302)
                         
    Three months ended September 30,   Nine months ended September 30,
Expenditures for Segment Assets   2017   2016   2017   2016
Radiochemical Products   $ 3,190   $ -   $ 3,190   $ -
Cobalt Products     -     -     -     -
Nuclear Medicine Standards     -     -     -     2,881
Radiological Services     3,436     -     13,277     40,813
Fluorine Products     2,010     2,451     12,213     11,170
Transportation     -     -     -     53,631
Total Segments     8,636     2,451     28,680     108,495
Corporate purchases     9,706     6,957     9,706     6,957
Total Consolidated   $ 18,342   $ 9,408   $ 38,386   $ 115,452
                         
    September 30,   December 31,            
Segment Assets   2017   2016            
Radiochemical Products   $ 269,388   $ 267,920            
Cobalt Products     1,676,881     1,414,240            
Nuclear Medicine Standards     481,767     502,361            
Radiological Services     238,775     171,354            
Fluorine Products     5,728,503     5,801,627            
Transportation     39,833     49,706            
Total Segments     8,435,147     8,207,208            
Corporate assets     4,131,162     3,172,057            
Total Consolidated   $ 12,566,309   $ 11,379,265